Ernexa Therapeutics Inc (ERNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,410 | 1,630 | 1,710 | 2,435 | 2,271 |
| Receivables | 53 | N/A | 145 | 186 | 383 |
| Other current assets | 0 | 0 | 792 | 1,132 | 856 |
| TOTAL | $8,714 | $1,732 | $2,793 | $4,089 | $4,265 |
| Non-Current Assets | |||||
| PPE Net | 569 | 594 | 689 | 928 | 2,489 |
| Intangibles | 2,044 | 2,044 | 0 | 0 | 0 |
| Other Non-Current Assets | 9,372 | 8,536 | 1,572 | 1,773 | 4,260 |
| TOTAL | $11,985 | $11,174 | $2,261 | $2,701 | $6,749 |
| Total Assets | $20,698 | $12,906 | $5,054 | $6,790 | $11,014 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 232 | 116 | 1,724 | 1,620 | 1,990 |
| Accounts payable and accrued liabilities | 1,812 | 1,275 | 275 | 397 | 787 |
| Accrued Expenses | 1,160 | 1,051 | 615 | 501 | 473 |
| Other current liabilities | N/A | N/A | 154 | 233 | 286 |
| TOTAL | $3,902 | $3,125 | $2,930 | $3,195 | $4,352 |
| Non-Current Liabilities | |||||
| Long Term Debt | 78 | 194 | 1,625 | 1,625 | N/A |
| Deferred Revenues | N/A | N/A | 120 | 377 | 383 |
| Other Non-Current Liabilities | 21,140 | 1,928 | 0 | 29 | 2,797 |
| TOTAL | $21,217 | $2,122 | $1,629 | $1,664 | $2,813 |
| Total Liabilities | $25,119 | $5,247 | $4,559 | $4,859 | $7,165 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 6 | 0 | 0 | 0 | 0 |
| Common Shares | 208 | 25,800 | 15 | 15 | 15 |
| Retained earnings | -55,083 | -18,141 | -136,187 | -134,706 | -132,675 |
| Other shareholders' equity | 1 | 0 | -214 | -215 | -291 |
| TOTAL | $-4,421 | $7,659 | $495 | $1,931 | $3,849 |
| Total Liabilities And Equity | $20,698 | $12,906 | $5,054 | $6,790 | $11,014 |